Neurological status predicts response to alpha-blockers in men with voiding dysfunction and Parkinson's disease.

Objectives: To evaluate predictors of the response to doxazosin, a selective alpha-adrenoceptor antagonist, when used for the treatment of lower urinary tract symptoms in men with Parkinson's disease.

Methods: In a prospective study, 33 consecutive men (mean age 59.2 ± 7.

Voiding dysfunction in patients with Parkinson's disease: impact of neurological impairment and clinical parameters.

Aims: We assessed the lower urinary tract symptoms (LUTS) of patients with Parkinson's disease (PD) and their association with different clinical parameters.

Methods: We prospectively evaluated 110 patients (84 men), with a mean age of 61.8 +/- 9.